Drug Intervention Institute partners with Harm Reduction Therapeutics to provide low-cost life-saving RiVive™ 3 mg naloxone nasal spray inside ONEbox™

by Brian Shim | Mar 1, 2024 | News

Higher naloxone doses have no impact on overdose survival, study shows

by Brian Shim | Feb 8, 2024 | News

Open Society Supports an Innovative Model to Make Naloxone Easier to Access Amidst the U.S. Overdose Crisis

by Brian Shim | Dec 12, 2023 | News

Partnership to Save Lives: Harm Reduction Therapeutics to donate 200,000 RiVive™ naloxone doses to Remedy Alliance for free distribution

by Brian Shim | Aug 17, 2023 | News

FDA APPROVAL OF RiVIVE™ IS A CRITICAL MILESTONE IN MAKING EMERGENCY TREATMENT OF OPIOID OVERDOSE MORE WIDELY AVAILABLE

by Brian Shim | Aug 1, 2023 | News